Age of Presentation: PFIC Types 1 and 2
PFIC type 1 typically presents in the neonatal period, while PFIC type 2 presents in early childhood, with both generally manifesting before 6 months of age. 1
PFIC Type 1 (FIC1 Deficiency)
PFIC1 characteristically presents during the neonatal period with signs and symptoms of liver disease, particularly severe pruritus 1. According to the EASL guidelines, this presentation occurs in the first year of life 2, with symptoms developing almost invariably before 6 months of age 3.
Key Clinical Features at Presentation:
- Severe pruritus (often the dominant symptom)
- Jaundice (moderate)
- Elevated serum transaminases, bilirubin, and bile acids
- Low or normal gamma-glutamyl transferase (GGT) - a critical distinguishing feature
- Extrahepatic manifestations: diarrhea, pancreatitis, failure to thrive, hearing deficits 1
Disease Trajectory:
Most patients develop end-stage liver disease before the end of the first decade of life 1.
PFIC Type 2 (BSEP Deficiency)
PFIC2 presents like PFIC1 in early childhood with clinical and biochemical signs of progressive liver disease 1. The presentation pattern is similar to PFIC1, with symptoms generally appearing around 3 months of age 4. Research indicates that symptoms tend to emerge earliest in patients with PFIC2 compared to other PFIC subtypes 4.
Key Clinical Features at Presentation:
- Progressive liver disease signs
- Low GGT levels (similar to PFIC1)
- Severe pruritus
- Jaundice
- Hepatomegaly and splenomegaly 4
Critical Distinction from PFIC1:
While the age of presentation is similar, PFIC2 carries a significantly higher risk of hepatocellular carcinoma at considerable rates 1, making early diagnosis and consideration for liver transplantation particularly important.
Diagnostic Timing Considerations
The systematic review by 4 confirms that common symptoms generally appeared at approximately 3 months of age across PFIC patients, with the earliest emergence in PFIC2. Historical data from 3 demonstrates that symptoms developed almost invariably before 6 months of age with severe pruritus and moderate jaundice as presenting features.
Important Clinical Pitfall:
The normal or low GGT in both PFIC1 and PFIC2 is essential for distinguishing these conditions from other pediatric cholestatic diseases like biliary atresia and Alagille syndrome, which present with elevated GGT 1. This biochemical marker should be checked early in any infant presenting with cholestasis.
Prognosis Related to Age of Presentation
Both PFIC1 and PFIC2 are chronic progressive cholestatic disorders of early childhood and adolescence 1. The median age at death in untreated or unsuccessfully treated patients was approximately 4 years in one study 4, with a mean age of 3.9 ± 2.4 years in another cohort 3. However, with appropriate surgical intervention (partial biliary diversion) or liver transplantation, many patients survive into adolescence and beyond 3.